DE69028513D1 - Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür - Google Patents

Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür

Info

Publication number
DE69028513D1
DE69028513D1 DE69028513T DE69028513T DE69028513D1 DE 69028513 D1 DE69028513 D1 DE 69028513D1 DE 69028513 T DE69028513 T DE 69028513T DE 69028513 T DE69028513 T DE 69028513T DE 69028513 D1 DE69028513 D1 DE 69028513D1
Authority
DE
Germany
Prior art keywords
antibodies
carrier
binding
immunotest
antiphospholipid antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028513T
Other languages
English (en)
Other versions
DE69028513T2 (de
Inventor
Eiji Matsuura
Yoshiko Igarashi
Hisato Nagae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Application granted granted Critical
Publication of DE69028513D1 publication Critical patent/DE69028513D1/de
Publication of DE69028513T2 publication Critical patent/DE69028513T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69028513T 1989-10-19 1990-10-19 Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür Expired - Fee Related DE69028513T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP27253689 1989-10-19
JP7496090 1990-03-23
JP18587090 1990-07-13
PCT/JP1990/001355 WO1991006006A1 (fr) 1989-10-19 1990-10-19 Excipient de liaison d'anticorps antiphospholipides, immuno-analyse utilisant cet excipient et kit associe

Publications (2)

Publication Number Publication Date
DE69028513D1 true DE69028513D1 (de) 1996-10-17
DE69028513T2 DE69028513T2 (de) 1997-02-06

Family

ID=27301664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028513T Expired - Fee Related DE69028513T2 (de) 1989-10-19 1990-10-19 Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür

Country Status (8)

Country Link
US (1) US5506110A (de)
EP (1) EP0450099B1 (de)
AT (1) ATE142789T1 (de)
AU (1) AU640699B2 (de)
CA (1) CA2044142A1 (de)
DE (1) DE69028513T2 (de)
NZ (1) NZ237535A (de)
WO (1) WO1991006006A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644163B2 (en) * 1990-04-06 1993-12-02 Yamasa Shoyu Co. Ltd. Methods for determining phospholipids and antibodies thereof
ATE164230T1 (de) * 1991-05-29 1998-04-15 Baxter Int 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
AU696638B2 (en) * 1993-11-16 1998-09-17 Yamasa Corporation Method of assaying antiphospholipid antibody and kit therefor
EP0714024B1 (de) * 1994-11-25 2002-01-30 Kyoto Dai-ichi Kagaku Co., Ltd. Vorrichtung und Verfahren zur Bestimmung von Wasserstoffperoxid
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
CA2256449A1 (en) * 1996-06-06 1997-12-11 Lajolla Pharmaceutical Company Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
US6177282B1 (en) 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
CA2376057A1 (en) * 1999-06-08 2000-12-14 La Jolla Pharmaceutical Company Valency platform molecules comprising aminooxy groups
EP1214083A4 (de) * 1999-09-22 2005-02-23 Liposome Corp Festphasen assay
JP2003535208A (ja) * 2000-06-08 2003-11-25 ラ ホヤ ファーマシューティカル カンパニー 高分子量ポリエチレン・オキシドを含む多価プラットホーム分子
US6777193B1 (en) * 2000-08-04 2004-08-17 Escuela Nacional De Ciencias Biologicas, Del Instituto Politecnico Nacional Methods for diagnostic and/or treatment of antiphospholipids antibodies-related diseases, and devices
GB0104057D0 (en) * 2001-02-20 2001-04-04 Babraham Inst Antiphospholipid antibody syndrome
DE10127712A1 (de) * 2001-06-07 2002-12-19 Torsten Witte Anwendung von IgM-Antikörpern gegen dsDNA beim systemischen Lupus erythematodes mit Nephritis
US20090068207A1 (en) * 2005-04-15 2009-03-12 Vascular Biogenics Ltd. Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
CA2603814C (en) * 2005-04-18 2013-08-27 Bio-Rad Laboratories, Inc. Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment
EP2261661A4 (de) * 2008-03-31 2011-04-20 Sekisui Medical Co Ltd Gereinigtes serumalbumin und immunologie-messverfahren
WO2016005354A1 (en) * 2014-07-07 2016-01-14 Ga Generic Assays Gmbh Autoantibody profiling in aps
CN117288948B (zh) * 2023-06-19 2024-06-04 无锡嘉润诊断技术有限公司 抗凝血酶原抗体检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668638A (en) * 1983-03-24 1987-05-26 The Liposome Company, Inc. Liposome composition for lupus assay
CA1327963C (en) * 1987-09-08 1994-03-22 Ryuichi Yokohari Autoantibody adsorbent and apparatus for removing autoantibodies using the same
CA2047742A1 (en) * 1989-02-27 1990-08-28 Corgenix, Inc. Method and diagnostic test kit for detection of anti-cardiolipin
CA2058769C (en) * 1990-04-06 1999-03-02 Steven Anthony Krilis Methods for determining phospholipids and antibodies thereof
AU644163B2 (en) * 1990-04-06 1993-12-02 Yamasa Shoyu Co. Ltd. Methods for determining phospholipids and antibodies thereof

Also Published As

Publication number Publication date
WO1991006006A1 (fr) 1991-05-02
EP0450099A1 (de) 1991-10-09
US5506110A (en) 1996-04-09
AU640699B2 (en) 1993-09-02
DE69028513T2 (de) 1997-02-06
EP0450099B1 (de) 1996-09-11
CA2044142A1 (en) 1991-04-20
EP0450099A4 (en) 1991-12-27
NZ237535A (en) 1993-05-26
AU6532190A (en) 1991-05-16
ATE142789T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
DE69028513D1 (de) Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
ATE425989T1 (de) Proteinreinigungsverfahren
FI97813B (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
FI891012A (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
DE3574184D1 (en) Support material for the use in immunoassays
ATE162079T1 (de) Verwendung von antikörper enthaltenden präparationen zur immunsuppression
FI864427A (fi) Menetelmä polypeptidin valmistamiseksi, joka on komplementaarinen ainakin osalle alkuperäistä peptidiä tai proteiinia, ja komplementaarisen polypeptidin käyttö
DE3865963D1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
FI903348A0 (fi) Menetelmä ligandien vapaan fraktion mittaamiseksi biologisissa nesteissä
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DK232988D0 (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8201226L (sv) Antikroppar mot proteiner
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
DK0415557T3 (da) Separation af antimetalchelat-antistoffer
DK162604C (da) Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel
GORDIS The Exegesis of Mishna and Baraita of Rav and Samuel. Part One: Sources of Laws and’Uqimtas
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
DK0439797T3 (da) Et antistof mod det carboxyl-terminale peptid af rotte-somatotropin-bindende protein
ATE171545T1 (de) Verfahren zur bestimmung des lysingehaltes von samen
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.
PT83501A (en) New vinblastine-protein conjugates - useful as antitumour agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee